Dr. Djulbegovic is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
MUSC Hematology Oncology
39 Sabin St, MSC 635
Charleston, SC 29425Phone+1 843-792-2646Fax+1 843-792-0644
Education & Training
University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 1988 - 1991
University of Sarajevo FOMClass of 1976- University of Louisville School of MedicineResidency, Internal Medicine
Certifications & Licensure
FL State Medical License 1998 - 2026
CA State Medical License 2017 - 2025
IN State Medical License 1994 - 2025
KY State Medical License 1990 - 2025
SC State Medical License 2023 - 2025- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
Publications & Presentations
PubMed
- Biomarker-derived fast-and-frugal decision tree for preemption of veno-occlusive disease/sinusoidal obstructive syndrome.Sophie Paczesny, Iztok Hozo, Benjamin Djulbegovic
Blood Advances. 2024-10-22 - What is the probability that higher versus lower quality of evidence represents true effects estimates?Benjamin Djulbegovic, Iztok Hozo, Despina Koletsi, Amy Price, David Nunan
Journal of Evaluation in Clinical Practice. 2024-10-07 - Comparison of Khorana vs. ONKOTEV predictive score to individualize anticoagulant prophylaxis in outpatients with cancer.Chiara Alessandra Cella, Benjamin Djulbegovic, Iztok Hozo, Florian Lordick, Vincenzo Bagnardi
European Journal of Cancer. 2024-09-01
Journal Articles
- Evaluation of Daratumumab for the Treatment of Multiple Myeloma in Patients with High-Risk Cytogenetic FactorsSusan Bal, Benjamin Djulbegovic, Saad Z Usmani, JAMA Oncology
- Bisphosphonates for Patients Diagnosed with Multiple MyelomaBenjamin Djulbegovic, MD, JAMA
Press Mentions
New Report Assesses COVID-19’S Trajectory and Implications for Medicare, Social SecurityJune 3rd, 2021- Use of a Decision Tree and Omics Data May Help Improve Survival Rates in Advanced NSCLCSeptember 2nd, 2020
US Food and Drug Administration Approvals of Drugs and Devices Based on Nonrandomized Clinical TrialsSeptember 11th, 2019- Join now to see all
Committees
- Member, Expert Panel, AABB 2015 - Present
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
